Zoya N. Demidenko_Semantic Scholar

Zoya N. Demidenko_Semantic Scholar


Dual phosphorylation controls Cdc25 phosphatases and mitotic entry
  • Dmitry V Bulavin, Yuichiro Higashimoto, +8 authors Albert J. Fornace
  • Biology, Medicine
  • Nature Cell Biology
  • 2003 (First Publication: 1 June 2003)
    • Negative regulation of the Cdc25C protein phosphatase by phosphorylation on Ser 216, the 14-3-3-binding site, is an important regulatory mechanism used by cells to block mitotic entry under normal… Continue Reading
  • Konstantin Salnikow, Thomas Kluz, +4 authors Mikhail V. Blagosklonny
  • Medicine, Biology
  • Molecular and cellular biology
  • 2002 (First Publication: 15 March 2002)
    • Hypoxia causes the accumulation of the transcription factor hypoxia-inducible factor 1 (HIF-1), culminating in the expression of hypoxia-inducible genes such as those for vascular endothelial growth… Continue Reading
    Pseudo-DNA damage response in senescent cells.
  • Tatiana V. Pospelova, Zoya N. Demidenko, Elena I Bukreeva, Valery A. Pospelov, Andrei V. Gudkov, Mikhail V. Blagosklonny
  • Biology, Medicine
  • Cell cycle
  • 2009 (First Publication: 15 December 2009)
    • Cellular senescence is currently viewed as a response to DNA damage. In this report, we showed that non-damaging agents such as sodium butyrate-induced p21 and ectopic expression of either p21 or p16… Continue Reading
  • Mikhail V. Blagosklonny, Shana Trostel, +5 authors Tito Fojo
  • Biology, Medicine
  • Cancer research
  • 2005 (First Publication: 15 August 2005)
    • Mutant p53 is a cancer-specific target for pharmacologic intervention. We show that histone deacetylase inhibitors such as FR901228 and trichostatin A completely depleted mutant p53 in cancer cell… Continue Reading
    Paradoxical suppression of cellular senescence by p53
  • Zoya N. Demidenko, Lioubov G. Korotchkina, Andrei V. Gudkov, Mikhail V. Blagosklonny
  • Medicine, Biology
  • Proceedings of the National Academy of Sciences
  • 2010 (First Publication: 10 May 2010)
    • The tumor suppressor p53 is a canonical inducer of cellular senescence (irreversible loss of proliferative potential and senescent morphology). p53 can also cause reversible arrest without senescent… Continue Reading
  • Lioubov G. Korotchkina, Olga V. Leontieva, Elena I Bukreeva, Zoya N. Demidenko, Andrei V. Gudkov, Mikhail V. Blagosklonny
  • Biology, Medicine
  • Aging
  • 2010 (First Publication: 1 June 2010)
    • Transient induction of p53 can cause reversible quiescence and irreversible senescence. Using nutlin-3a (a small molecule that activates p53 without causing DNA damage), we have previously identified… Continue Reading

    When people mention contemporary medicine, accuracy plays one of the most significant roles and human lives are literally dependent on it. Hence, any researches related to medicine are required to meet the top standards. The issue today is that any conclusions of researches can be shared online and used as a reference without being thoroughly checked and approved. Mikhail (Misha) Blagosklonny of Oncotarget perfectly understood this challenge and tried to create an alternative solution. That’s how a weekly oncology-focused research journal named “Oncotarget” has been founded back in 2010. The main principle of this journal is related to Altmetric scores that are used as a quality indicator. That assists both readers and authors to validate publications with Altmetric Article Reports that create “real-time feedback containing data summary related to a particular publication.” Oncotarget website has a full publications list with respective scores higher than 100 as well as reports discussed above. Mikhail (Misha) Blagosklonny glad to share his new approach and hopes it creates the required assistance to anyone, who has interest in oncology.
    Blagosklonny
    “A diagnostic autoantibody signature for primary cutaneous melanoma” has the Altmetric score of 594. This paper was released back in 2018 by Oncotarget and written by different experts from Hollywood Private Hospital, Edith Cowan University, Dermatology Specialist Group, St. John of God Hospital and The University of Western Australia. The introduction of the study mentions that “recent data shows that Australians are four times more likely to develop a cancer of the skin than any other type of cancer”, and shares an insight on melanoma that “is curable by surgical excision in the majority of cases, if detected at an early stage.”
    The publication has got an Altmetric score of 594. Mikhail (Misha) Blagosklonny realizes that most of readers are willing to comprehend the very meaning of it. Based on the Altmetric website, the score relates to “how many people have been exposed to and engaged with a scholarly output.” Likewise, the article about melanoma, was used for citations in different news articles 69 times. Moreover, it was quoted in 2 online blogs, as well as 25 Tweets on Twitter and 1 Facebook post. FOX23 of Tulsa, Oklahoma has headlined their report on July 20, 2018 as “New blood test could detect skin cancer early”, using the main content of Australia study
    Another Oncotarget’s research with a top score of 476, is “Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moon-shot,”. This study has appeared in 60 news stories, 1 online blog post and 6 Twitter posts. The majority of public may have seen a short overview only, however those who visit Mikhail (Misha) Blagosklonny at Oncotarget, do get useful scientific facts. Oncotarget is proud to have the ability to share with online viewers this highly appreciated and top-quality information, that is trustworthy and reliable.
    https://www.scientificamerican.com/article/a-new-path-to-longevity/

    Comments

    Post a Comment

    Popular posts from this blog

    Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence

    Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence Abstract Inhibition of mTOR by rapamycin prevents cellular senescence. Here we investigated the effects of MEK and PI-3K on cellular senescence. Unlike LY294002 (PI-3K inhibitor), both U0126 and PD98059 (MEK inhibitors) did not significantly decrease beta-Gal staining in aging human fibroblasts and fibrosarcoma cells. However, using a sensitive, functional method, we identified that not only LY294002 but also U0126 prevented irreversible loss of proliferative potential associated with cellular senescence. At concentrations that blocked S6 phosphorylation, rapamycin, U0126 and LY294002 equally prevented senescence. Furthermore, there was no additive effect by combining of rapamycin with either U0126 or LY294002. Taken together this suggests that (a) simultaneous activation of PI-3K and MEK is required to ensure cellular senescence and (b) U0126 and LY294002 suppress senescence vi
    Read more

    Publications by authors named "Zoya N Demidenko"

    Publications by authors named "Zoya N Demidenko" Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA. When the cell cycle is arrested, even though growth-promoting pathways such as mTOR are still active, then cells senesce. For example, induction of either p21 or p16 arrests the cell cycle without inhibiting mTOR, which, in turn, converts p21/p16-induced arrest into senescence (geroconversion). Here we show that geroconversion is accompanied by dramatic accumulation of cyclin D1 followed by cyclin E and replicative stress. When p21 was switched off, senescent cells (despite their loss of proliferative potential) progressed through S phase, and levels of cyclins D1 and E dropped. Most cells entered mitosis and then died, either during mitotic arrest or after mitotic slippage, or underwent endoreduplication. Next, we investigated whether inhibition of mTOR would prevent a
    Read more